{
    "root": "9c53374f-97ca-41e6-8e1b-0d2bda492191",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "MERCAPTOPURINE",
    "value": "20241122",
    "ingredients": [
        {
            "name": "MERCAPTOPURINE",
            "code": "E7WED276I5"
        },
        {
            "name": "ASPARTAME",
            "code": "Z0H242BBR1"
        },
        {
            "name": "ETHYLPARABEN SODIUM",
            "code": "Z0D00IVA10"
        },
        {
            "name": "HYDROCHLORIC ACID",
            "code": "QTT17582CB"
        },
        {
            "name": "METHYLPARABEN SODIUM",
            "code": "CR6K9C2NHK"
        },
        {
            "name": "POTASSIUM SORBATE",
            "code": "1VPU26JZZ4"
        },
        {
            "name": "RASPBERRY JUICE",
            "code": "427AYI9PDE"
        },
        {
            "name": "CORN SYRUP",
            "code": "9G5L16BK6N"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "SODIUM HYDROXIDE",
            "code": "55X04QC32I"
        },
        {
            "name": "SUCROSE",
            "code": "C151H8M554"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R"
        },
        {
            "name": "XANTHAN GUM",
            "code": "TTV12P4NEE"
        }
    ],
    "indications": "Mercaptopurine is a nucleoside metabolic inhibitor indicated for the treatment of patients with acute lymphoblastic leukemia (ALL) as part of a combination chemotherapy maintenance regimen. ( 1.1 )",
    "contraindications": "• The recommended starting dosage of mercaptopurine oral suspension is 1.5 mg/kg to 2.5 mg/kg (50 mg/m 2 to 75 mg/m 2 ) orally once daily as part of a combination chemotherapy maintenance regimen. Adjust dose to maintain desirable absolute neutrophil count and for excessive myelosuppression. ( 2.1 ) • Renal Impairment : Use the lowest recommended starting dose or increase the dosing interval. ( 2.3 , 8.6 ) • Hepatic Impairment : Use the lowest recommended starting dose. ( 2.3 , 8.7 )",
    "warningsAndPrecautions": "Mercaptopurine Oral Suspension is supplied as 2,000 mg/100 mL (20 mg/mL) pink to brown viscous liquid in amber glass multiple-dose bottles. In addition, a press-in bottle adapter and two oral dispensing syringes (one 1 mL and one 5 mL) are provided. \n                  Each carton NDC 0054-4582-49 contains 1 bottle of Mercaptopurine Oral Suspension NDC 0054-4582-49.\n                  \n                     \n                        •Store Mercaptopurine Oral Suspension at 20º to 25ºC (68º to 77ºF) [see USP Controlled Room Temperature]. Store in a dry place.\n                  \n                  Mercaptopurine is a hazardous drug. Follow special handling and disposal procedures.1",
    "adverseReactions": "None."
}